Article
Pharmacogenomic association of nonsynonymous SNPs in SIGLEC12, A1BG, and the selectin region and cardiovascular outcomes.
Hypertension (Dallas, Tex. : 1979) - 1 Jul 2013
McDonough Caitrin W, Gong Yan, Padmanabhan Sandosh, Burkley Ben, Langaee Taimour Y, Melander Olle, Pepine Carl J, Dominiczak Anna F, Cooper-Dehoff Rhonda M, Johnson Julie A
Abstract excerpt
We sought to identify novel pharmacogenetic markers associated with cardiovascular outcomes in patients with hypertension on antihypertensive therapy. We genotyped a 1:4 case:control cohort (n=1345) on the Illumina HumanCVD Beadchip from the INternational VErapamil SR-Trandolapril STudy (INVEST), where participants were randomized to a β-blocker strategy or a calcium channel blocker strategy. Genome-spanning...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
